U.S. Tobacco Stock News

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...

Catalyst Pharmaceuticals (NasdaqCM:CPRX) reported record full year and Q4 2025 results, highlighting organic growth across its portfolio. The company noted continued market uptake of its lead rare disease treatments, including AGAMREE and FIRDAPSE. Management discussed how recent alliances and product momentum position Catalyst within the rare disease treatment space. Catalyst Pharmaceuticals focuses on therapies for rare neurological and neuromuscular conditions, an area where treatment...

INVO Fertility has joined the Progyny (NasdaqGS:PGNY) provider network, adding its clinic to Progyny's fertility benefits platform. The partnership expands access to employer sponsored fertility care for patients in Wisconsin and nearby regions. This development broadens Progyny's provider footprint and increases potential touchpoints with covered employees seeking fertility treatment. Progyny runs a fertility benefits platform that connects employer sponsored health plans with a network of...

If you are wondering whether PNC Financial Services Group's current share price lines up with its underlying worth, you are in the right place for a clear, valuation focused look at the stock. The shares last closed at US$212.37, after a 4.7% decline over the past week and a 9.2% decline over the past month, while the 1 year return sits at 23.0% and the 3 year return at 73.6%. These moves come as investors continue to weigh broader sentiment toward large US banks and react to ongoing sector...

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...

If you are wondering whether United States Antimony is still offering value after its recent run, you are not alone. This article is built to help you weigh that up clearly. The stock last closed at US$9.26, with returns of 3.9% over 7 days, a 4.0% decline over 30 days, a 56.2% gain year to date, and a very large 1 year return alongside a multi fold gain over 3 years. Recent coverage has focused on renewed investor interest in antimony and related materials, as the company features in...

Stock performance snapshot and recent returns Lionsgate Studios (LION) has caught investors' attention after a recent move in its share price. The stock closed at $9.43, with a 3.85% gain over the past day and 14.44% over the past week. Looking at slightly longer periods, the shares show a 2.17% return over the past month and 32.82% over the past 3 months. The 1 year total return stands at 18.31%, and the 3 year total return at 11.86%. See our latest analysis for Lionsgate Studios. The recent...

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...

SCCM Enhanced Equity Income Fund has fully exited its position in Kenvue (NYSE:KVUE). The decision highlights ongoing business challenges, including US consumer spending pressures and delayed seasonality in key product lines. Operational headwinds in China, rising competition, and market share erosion are central to current investor concerns. Kenvue, trading at $18.19, is drawing fresh attention after the SCCM Enhanced Equity Income Fund chose to exit its position entirely. The stock is up...

Kyndryl Holdings (NYSE:KD) has been hit with multiple securities class action lawsuits following disclosures of material weaknesses in its internal controls. The company also reported the departures of key executives, including its Chief Financial Officer and General Counsel. Investors are assessing what these control issues and leadership changes could mean for financial reporting quality and potential legal exposure. Kyndryl Holdings, trading at about $13.14, has seen sharp volatility,...

Intuitive Machines, NasdaqGM:LUNR, closed a $175 million equity investment alongside a flagship defense contract win through its Lanteris Space Systems subsidiary. The contract covers development of advanced spacecraft platforms for missile tracking in defense missions. The equity funding is aimed at supporting satellite communications and deep space initiatives across the broader Intuitive Machines business. Intuitive Machines, trading at $18.62, operates at the intersection of commercial...

If you are wondering whether CF Industries Holdings is priced attractively right now, you are not alone. This article will walk through what the current share price might imply about value. The stock last closed at US$104.71, with returns of 8.9% over 7 days, 16.6% over 30 days, 30.7% year to date, 40.4% over 1 year, 33.3% over 3 years, and 136.3% over 5 years, which can change how investors think about both upside potential and risk. Recent coverage has focused on how CF Industries fits...

Why Hagerty’s 2025 results and new Markel arrangement matter for investors Hagerty (HGTY) has drawn fresh attention after reporting 2025 earnings alongside new 2026 guidance that reflects a fronting arrangement with Markel, shifting premium retention, revenue treatment, and expected profitability patterns. See our latest analysis for Hagerty. Those 2025 results and the new Markel fronting arrangement landed in a softer share price backdrop, with a 30 day share price return of a 14.67% decline...

Semrush Holdings (NYSE:SEMR) has launched Spotlight 2026, an AI focused marketing conference centered on brand visibility in the AI search era. The company has introduced an official Semrush app within ChatGPT to bring its marketing toolkit into the conversational AI environment. These moves come as Semrush continues through its planned acquisition process with Adobe. Semrush operates as a digital marketing platform, with tools that help businesses manage search visibility, content, and...

Japan reimbursement approval reshapes Optune Lua access NovoCure (NVCR) just received reimbursement approval in Japan for its Optune Lua device through the National Health Insurance, a regulatory milestone that widens access for eligible non small cell lung cancer patients. For you as an investor, this decision ties product adoption directly to a large, insurance backed market. It adds a fresh piece of information to weigh against NovoCure's existing financial profile and share price...

Why TETRA Technologies is back in focus after a record 2025 TETRA Technologies (TTI) is on investors radar after reporting a record 2025, supported by strong offshore completion fluids activity, improved adjusted EBITDA margins, and plans to scale key projects across Arkansas, Argentina, and desalination. See our latest analysis for TETRA Technologies. The latest record-year update and expansion plans have come alongside a share price of US$8.60 and a sharp 30 day share price return of...

Builders FirstSource (NYSE:BLDR) recently reported an earnings miss alongside weaker operating metrics. The company highlighted ongoing pressure on revenue and EPS, reflecting sector wide headwinds in building materials. These operational challenges come as the stock trades around $95.99 and investors reassess the company’s growth and profitability profile. For investors watching NYSE:BLDR, the latest results come after a tough stretch in the share price, with the stock down 6.5% over the...

Root, Inc. previously reported fourth-quarter 2025 revenue of US$397 million, up from US$326.7 million a year earlier, with net income of US$5.1 million compared with US$20.9 million. For 2025 overall, Root lifted revenue to US$1.52 billion and increased net income to US$38.3 million, but its fourth-quarter profit was lower than the prior year despite higher sales. Next, we’ll examine how Root’s higher full-year revenue and earnings, alongside weaker quarterly profit, may influence its...

International Seaways (NYSE:INSW) has announced a major supplemental dividend to be paid alongside its regular quarterly dividend. The Board of Directors approved the additional payout, signaling a significant return of capital to shareholders. The decision reflects management's view of the company’s current financial position and cash resources. International Seaways focuses on crude and product tanker shipping, a segment that tends to be closely linked to global energy trade and fleet...

In recent days, Hercules Capital, Inc. has been challenged by a short-seller report questioning its software loan valuations and dividend sustainability, prompting a detailed company rebuttal defending its valuation processes, portfolio quality, and cash flow coverage. At the same time, Hercules has highlighted record 2025 commitments, an affirmed investment-grade rating, and insider share purchases, underscoring a tension between external concerns over risk and the company’s own message of...

Hycroft Mining Holding (NasdaqCM:HYMC) reports a 55% increase in its gold and silver mineral resource base. The company eliminates all debt and shifts its focus from production to exploration and development. Hycroft launches its largest exploration drill program to date. The stock is added to the MSCI Small Cap Index, increasing its visibility with institutional investors. Hycroft Mining Holding, trading at $47.665, has gone through a major reset that is drawing fresh attention from the...